血栓切除設備市場規模、佔有率和成長分析（按技術、類型、應用和地區）- 產業預測 2025-2032

2023 年血栓切除設備市場規模價值 20 億美元，預計將從 2024 年的 21.4 億美元成長到 2032 年的 36.5 億美元，預測期間（2025-2032 年）的複合年成長率為 6.9%。

由於心血管疾病發病率上升、技術進步和人口老化，全球血栓切除設備市場預計將大幅成長。微創技術的創新，例如用於移除血栓的血栓摘取支架裝置，顯著改善了患者的治療效果，同時減少了手術併發症和恢復時間。隨著老年人口的增加，對有效血栓清除解決方案的需求也隨之增加，因為老年人更容易患心血管疾病和血栓形成。這種人口結構的變化凸顯了市場對先進治療方案的需求。因此，美國血栓切除設備市場預計在未來預測期內以穩定的複合年成長率持續成長，滿足老齡化人口的關鍵醫療需求。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

血栓切除設備市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 機械血栓切除術
• 血栓抽吸術
• 流變性血栓切除術

血栓切除設備市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 自動化設備
• 手動裝置

血栓切除設備市場規模（按用途和複合年成長率） (2025-2032)

• 市場概況
• 可重複使用的設備
• 免洗設備

血栓切除設備市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 周圍疾病
• 冠狀動脈疾病
• 神經系統疾病

血栓切除設備市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic（Ireland）
• Abbott（United States）
• Boston Scientific（United States）
• Stryker（United States）
• Johnson & Johnson（United States）
• Penumbra（United States）
• Terumo（Japan）
• Koninklijke Philips（Netherlands）
• Becton, Dickinson and Company（BD）（United States）
• Merit Medical Systems（United States）
• Teleflex Incorporated（United States）
• AngioDynamics（United States）
• Edwards Lifesciences（United States）
• Cerenovus（United States）
• Vascular Solutions（United States）
• Balt Extrusion（United States）
• Acandis（Germany）

結論和建議

Thrombectomy Devices Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.14 billion in 2024 to USD 3.65 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global market for thrombectomy devices is poised for substantial growth due to the rising prevalence of cardiovascular diseases, technological advancements, and an aging population. Innovations in minimally invasive technologies, like stent retriever devices for clot removal, have significantly enhanced patient outcomes while decreasing procedural complications and recovery times. As the geriatric population expands, so does the demand for effective thrombectomy solutions, given that older adults are more prone to cardiovascular issues and blood clot formation. This demographic shift underscores the necessity for advanced treatment options in the market. Consequently, the U.S. thrombectomy devices market is set for sustainable growth at a consistent CAGR in the upcoming forecast period, addressing critical healthcare needs in an aging society.

Top-down and bottom-up approaches were used to estimate and validate the size of the Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Thrombectomy Devices Market Segments Analysis

Global Thrombectomy Devices Market is segmented by Technology, Type, Utility, Application and region. Based on Technology, the market is segmented into Mechanical Thrombectomy, Aspiration Thrombectomy and Rheolytic Thrombectomy. Based on Type, the market is segmented into Automated Devices and Manual Devices. Based on Utility, the market is segmented into Reusable Devices and Disposable Devices. Based on Application, the market is segmented into Peripheral Diseases, Coronary Disease and Neural Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Thrombectomy Devices Market

The rising prevalence of cardiovascular diseases, such as strokes and heart attacks, is a major driving force behind the thrombectomy devices market. As more individuals age and adopt sedentary lifestyles, the incidence of these health issues continues to escalate. Thrombectomy devices are crucial for the rapid removal of blood clots, thereby restoring normal blood circulation and significantly improving patient outcomes. This increasing demand for effective treatment options highlights the importance of thrombectomy devices in modern medical practice, ultimately contributing to their growth within the healthcare industry. The combination of an aging population and lifestyle factors creates a pressing need for these innovative devices.

Restraints in the Thrombectomy Devices Market

The Thrombectomy Devices market faces certain restraints due to the inherent risks associated with thrombectomy procedures, much like other medical interventions. Complications such as vessel injury, bleeding, infection, or the risk of a clot becoming dislodged and leading to an embolism can arise. Such safety and efficacy concerns surrounding these devices may affect the choices made by both healthcare providers and patients, ultimately impacting the market's growth potential. These apprehensions regarding potential adverse outcomes could deter adoption rates, thereby posing challenges to the overall advancement and expansion of the thrombectomy devices market.

Market Trends of the Thrombectomy Devices Market

The Thrombectomy Devices market is experiencing a significant upward trend, driven by the increasing incidence of ischemic stroke, prompting heightened demand for sophisticated medical technologies. Key market players are intensifying their research and development initiatives to introduce innovative thrombectomy solutions, including advanced aspiration devices, clot retrievers, and specialized catheters. These devices are engineered with state-of-the-art technology that enhances tracking precision, facilitates seamless clot retrieval, and boasts user-friendly operations. As these advanced solutions become more accessible, healthcare professionals are better equipped to tackle the complexities of ischemic stroke treatment, ultimately leading to improved patient outcomes and a more resilient healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Thrombectomy Devices Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Mechanical Thrombectomy
• Aspiration Thrombectomy
• Rheolytic Thrombectomy

Global Thrombectomy Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Automated Devices
• Manual Devices

Global Thrombectomy Devices Market Size by Utility & CAGR (2025-2032)

• Market Overview
• Reusable Devices
• Disposable Devices

Global Thrombectomy Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Peripheral Diseases
• Coronary Disease
• Neural Diseases

Global Thrombectomy Devices Market Size & CAGR (2025-2032)

• North America (Technology, Type, Utility, Application)
  • US
  • Canada
• Europe (Technology, Type, Utility, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Type, Utility, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Type, Utility, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Type, Utility, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerenovus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt Extrusion (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations